Cover Image
市場調查報告書

感染疾病診斷市場:各產品(設備、試劑、服務、軟體)、各用途(C型肝炎、AIDS、結核)、各技術(PCR、INAAT、DNA定序、混合化)、各終端用戶(醫院、實驗室) - 趨勢及全球市場預測

Infectious Disease Diagnostics Market: Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (Hospital, Laboratories): Global Forecast to 2019

出版商 MarketsandMarkets 商品編碼 322724
出版日期 內容資訊 英文 210 Pages
訂單完成後即時交付
價格
Back to Top
感染疾病診斷市場:各產品(設備、試劑、服務、軟體)、各用途(C型肝炎、AIDS、結核)、各技術(PCR、INAAT、DNA定序、混合化)、各終端用戶(醫院、實驗室) - 趨勢及全球市場預測 Infectious Disease Diagnostics Market: Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (Hospital, Laboratories): Global Forecast to 2019
出版日期: 2015年01月08日 內容資訊: 英文 210 Pages
簡介

感染疾病診斷市場預計至2019年年複合成長率為7.9%,達到181億5,620萬美元。免疫診斷和生物化學的特性化等傳統的診斷技術是最大市場區隔,不過,微陣列和恆溫核酸增幅技術(INAAT)等急速成長。

本報告提供全球感染疾病診斷市場相關調查、各產品、用途、技術、終端用戶的趨勢、各地區趨勢,及參與企業簡介等彙整資料。

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 高級見解

第5章 市場概要

  • 簡介
  • 市場區隔
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會
    • 課題
    • 成功的秘訣
    • 問題點

第6章 產業概要

  • 簡介
  • 供應鏈分析
  • PEST分析
  • 產業趨勢
  • 策略性基準

第7章 各產品感染疾病診斷市場

  • 簡介
  • 設備及分析設備
  • 消耗品
    • 化驗及試劑
  • 服務及軟體

第8章 各用途感染疾病診斷市場

  • 簡介
  • B型肝炎
  • C型肝炎
  • AIDS
  • 結核
  • 沙眼衣原體及淋菌
  • 人類乳突瘤病毒感染
  • MRSA院內感染
  • 其他

第9章 各技術感染疾病診斷市場

  • 簡介
  • 傳統的診斷技術
    • 免疫診斷
    • 顯微鏡檢驗
    • 生物化學的特性化
  • 分子診斷
    • PCR
    • INAAT
    • 混合化
    • DNA定序及次世代定序
    • 微陣列
    • 其他

第10章 各終端用戶感染疾病診斷市場

  • 簡介
  • 醫院及實驗室
  • 參照實驗室
  • 診療部門實驗室
  • 學術機構(學術醫療中心/研究實驗室、大學內實驗室)
  • 其他

第11章 各地區分析

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第12章 競爭環境

第13章 企業簡介

  • Abbott Laboratories
  • Becton, Dickinson & Co.
  • Biomerieux
  • Bio-Rad Laboratories
  • Alere, Inc.
  • Thermo Fisher Scientific, Inc. ?
  • Siemens Healthcare
  • Roche Diagnostics
  • Danaher Corporation
  • Johnson and Johnson

第14章 附錄

圖表

目錄
Product Code: MD 3088

Increasing Prevalence of Deadly Infectious Disease and Need For Highly Specific and Sensitive Technologies for Rapid Diagnosis to Drive Growth of the IDD Market

The global IDD market report is segmented by product, application, technology, end user, and region. The immunodiagnostics and polymerase chain reaction technology segments accounted for the lion's share of the global IDD market by technology, owing to growing need for advanced technologies for rapid diagnosis of infectious diseases.

On the basis of application, the IDD market is categorized into the Hepatitis B, Hepatitis C, Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG), human papillomavirus (HPV), methicillin-resistant Staphylococcus aureus (MRSA), and others (Influenza, Ebola, Typhoid, Malaria, and Dengue, among others). Hospital-acquired MRSA infections, human papillomavirus, and AIDS are expected to be new revenue pockets in the applications market. The rising prevalence of these diseases globally is the major factor driving the growth of the aforementioned markets.

On the basis of product, the IDD market is segmented into instruments, consumables (reagents and assays), and software & services. Among products, consumables are estimated to be the fastest-growing market owing to its growing adoption in emerging infectious disease diagnostics worldwide.

On the basis of end user, the market is segmented into hospital laboratories, reference labs, physician's office labs, academics, and others (blood banks, local public health laboratories, home health agencies, nursing homes, point of care, self-testing). Hospital laboratories are expected to be the fastest-growing market in the forecast period. Owing to the complexity and highly specialized nature of diagnostic tests for infectious diseases, hospital laboratories are expected to grow at the fastest rate in the forecast period, from 2014 to 2019.

From an insight perspective, this report focuses on qualitative data, market size, and the growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis, such as market dynamics (drivers, restraints, opportunities, and threats), winning imperatives, and burning issues. The report also offers market sizes and related growth of various segments in the industry. It focuses on emerging and high-growth segments of the IDD market, high-growth regions, and initiatives of respective governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles offer basic views on key players in the IDD market and their product portfolios, recent developments, and key strategies adopted. The abovementioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, approaches, R&D investments for innovations in products and technologies, and levels of output, in order to remain successful.

Table of Contents

1. Introduction

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Markets Covered
  • 1.4. Years Considered for the Study
  • 1.5. Currency
  • 1.6. Limitations
  • 1.7. Stakeholders

2. Research Methodology

  • 2.1. Market Size Estimation
  • 2.2. Market Crackdown and Data Triangulation
    • 2.2.1. Key Data From Secondary Sources
    • 2.2.2. Key Data From Primary Sources
      • 2.2.2.1. Key Industry Insights
    • 2.2.3. Assumptions

3. Executive Summary

4. Premium Insights

  • 4.1. Market to Grow at A Modest Rate
  • 4.2. Market, By Product
  • 4.3. Global Market, By Application
  • 4.4. Global Market, By Technique
  • 4.5. Global Market, By End User
  • 4.6. Market, By Geography
  • 4.7. Lifecycle Analysis, By Region

5. Market Overview

  • 5.1. Introduction
  • 5.2. Market Segmentation
    • 5.2.1. Market, By Product
    • 5.2.2. Market, By Application
    • 5.2.2. Market, By Technique
    • 5.2.3. Market, By End User
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
      • 5.3.1.1. High Prevalence Rate of Infectious Diseases to Drive the Growth of Idd Market
      • 5.3.1.2. Slow Turnaround Time of the Current Diagnostic Cycle Has Created Demand for Rapid Diagnostic Procedures
      • 5.3.1.3. New Rapid Diagnostic Tests Hold Promise for the Improved Management and Control of Infectious Diseases
      • 5.3.1.4. Increased Funding to Propel the Idd Market
    • 5.3.2. Restraints
      • 5.3.2.1. Rising Healthcare Costs Limits the Usage of Novel Infectious Disease Diagnostic Techniques
      • 5.3.2.2. Complex Regulatory Framework to Delay Approvals of New Diagnostic Tests
    • 5.3.3. Opportunities
      • 5.3.3.1. Huge Growth Prospects in Developing Countries
      • 5.3.3.2. Advances in Research and Development for Better Diagnostic Procedures to offer New Growth Opportunities
      • 5.3.3.3. Personalized Medicine
    • 5.3.4. Challenges
      • 5.3.4.1. Dearth of Trained Professionals Restricting the Appropriate Use of New Diagnostic Tests
      • 5.3.4.2. Difficulties Regarding Reimbursement for New Diagnostic Tests May Hamper Innovation
    • 5.3.5. Winning Imperatives
      • 5.3.5.1. Shift in the Focus From Centralized Laboratories to Decentralized Point-of-Care Testing Augmenting the Growth of Idd Market
    • 5.3.6. Burning Issues
      • 5.3.6.1. Global Regulatory Environment Restricting the Clearance and Marketing of Infectious Disease Diagnostic Products

6. Industry Insights

  • 6.1. Introduction
  • 6.2. Supply Chain Analysis
    • 6.2.1. Key Influencers
  • 6.3. Pest Analysis
    • 6.3.1. Political Factors
    • 6.3.2. Economical Factors
    • 6.3.3. Social Factors
    • 6.3.4. Technological Factors
  • 6.4. Industry Insights
  • 6.5. Strategic Benchmarking
    • 6.5.1. New Product Launches

7. Infectious Disease Diagnostics Market, By Product

  • 7.1. Introduction
  • 7.2. Instruments & Analyzers
  • 7.3. Consumables
    • 7.3.1. Assays and Reagents
  • 7.4. Services & Softwares

8. Infectious Disease Diagnostics Market, By Application

  • 8.1. Introduction
  • 8.2. Hepatitis B
  • 8.3. Hepatitis C
  • 8.4. Aids
  • 8.5. Tuberculosis (TB)
  • 8.6. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
  • 8.7. Human Papillomavirus (HPV) Infection
  • 8.8. Methicillin-Resistant Staphylococcus Aureus (MRSA) Hospital Acquired Infection
  • 8.9. Others (Influenza, Ebola, Typhoid, Malaria, Dengue)

9. Infectious Disease Diagnostics Market, By Technique

  • 9.1. Introduction
  • 9.2. Traditional Diagnostic Techniques
    • 9.2.1. Immunodiagnostics
    • 9.2.2. Microscopy
    • 9.2.3. Biochemical Characterization
  • 9.3. Molecular Diagnostics
    • 9.3.1. PCR
    • 9.3.2. INAAT
    • 9.3.3. Hybridization
    • 9.3.4. DNA Sequencing & NGS
    • 9.3.5. Microarray
    • 9.3.6. Others

10. Infectious Disease Diagnostics Market, By End User

  • 10.1. Introduction
  • 10.2. Hospitals Laboratories
  • 10.3. Reference Labs
  • 10.4. Physician office Labs
  • 10.5. Academics (Acadmic Medical Centers/Research Labs, University Labs)
  • 10.6. Others (Blood Banks, Local Public Health Laboratories, Home Health Agencies, Nursing Homes, Point of Care, Self Testing)

11. Geographic Analysis

  • 11.1. Introduction
  • 11.2. North America
    • 11.2.1. U.S.
    • 11.2.2. Canada
  • 11.3. Europe
  • 11.4. Asia-Pacific
  • 11.5. Rest of the World (ROW)

12. Competitive Landscape

  • 12.1. Overview
  • 12.2. Market Share Analysis
  • 12.3. Battle for Market Share: New Product Launches Was the Key Strategy
  • 12.4. New Product Launches
  • 12.5. Agreements, Partnerships, and Collaborations
  • 12.6. Acquisitions
  • 12.7. Expansions
  • 12.8. Other Developemnts

13. Company Profile

  • 13.1. Abbott Laboratories
    • 13.1.1. Business Overview
    • 13.1.2. Product Portfolio
    • 13.1.3. Key Strategy
    • 13.1.4. Recent Developments
  • 13.2. Becton, Dickinson & Co.
    • 13.2.1. Business Overview
    • 13.2.2. Product Portfolio
    • 13.2.3. Key Strategy
    • 13.2.4. Recent Developments
  • 13.3. Biomérieux
    • 13.3.1. Business Overview
    • 13.3.2. Product Portfolio
    • 13.3.3. Key Strategy
    • 13.3.4. Recent Developments
    • 13.3.5. SWOT Analysis
    • 13.3.6. MNM View
  • 13.4. Bio-Rad Laboratories
    • 13.4.1. Business Overview
    • 13.4.2. Products & Services
    • 13.4.3. Key Strategy
    • 13.4.4. Recent Developments
  • 13.5. Alere, Inc.
    • 13.5.1. Business Overview
    • 13.5.2. Product Portfolio
    • 13.5.3. Key Strategy
    • 13.5.4. Recent Developments
  • 13.6. Thermo Fisher Scientific, Inc.
    • 13.6.1. Products & Services
    • 13.6.2. Key Strategy
    • 13.6.3. Recent Developments
  • 13.7. Siemens Healthcare
    • 13.7.1. Business Overview
    • 13.7.2. Key Strategy
    • 13.7.3. Recent Developments
  • 13.8. Roche Diagnostics
    • 13.8.1. Business Overview
    • 13.8.2. Product Portfolio
    • 13.8.3. Key Strategy
    • 13.8.4. Recent Developments
  • 13.9. Danaher Corporation
    • 13.9.1. Business Overview
    • 13.9.2. Product Portfolio
    • 13.9.3. Key Strategy
    • 13.9.4. Recent Developments
  • 13.10. Johnson and Johnson
    • 13.10.1. Business Overview
    • 13.10.2. Product Portfolio
    • 13.10.3. Key Strategy
    • 13.10.4. Recent Developments

14. Appendix

  • 14.1. Insights of Industry Experts
  • 14.2. Discussion Guide
  • 14.3. Introducing RT: Real-Time Market Intelligence
  • 14.4. Available Customizations
  • 14.5. Related Reports

List of Tables

  • Table 1: Global Market Size, By Product, 2012-2019 ($Million)
  • Table 2: Market Size for Instruments, By Geography, 2012-2019 ($Million)
  • Table 3: North American Infectious Disease Diagnostics Market Size for Instruments, By Country, 2012-2019 ($Million)
  • Table 4: Market Size for Reagents, By Geography, 2012-2019 ($Million)
  • Table 5: North American Infectious Disease Diagnostics Market Size for Reagents, By Country, 2012-2019 ($Million)
  • Table 6: Market Size for Services and Softwares, By Geography, 2012-2019 ($Million)
  • Table 7: ROW Fluorescence Infectious Disease Diagnostics Market Size, By Country, 2012-2019 ($Million)
  • Table 8: North American Infectious Disease Diagnostics Market Size for Services and Softwares, By Country, 2012-2019 ($Million)
  • Table 9: Global Infectious Disease Diagnostics Market Size, By Technique, 2012-2019 ($Million)
  • Table 10: Global Traditional Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 11: Global Molecular Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 12: Market Size for Immunodiagnostics, By Geography, 2012-2019 ($Million)
  • Table 13: North American Infectious Disease Diagnostics Market Size for Immunodiagnostics, By Country, 2012-2019 ($Million)
  • Table 14: Market Size for Microscopy, By Geography, 2012-2019 ($Million))
  • Table 15: North American Infectious Disease Diagnostics Market Size for Microscopy, By Country, 2012-2019 ($Million)
  • Table 16: Market Size for Biochemical Characterization, By Geography, 2012-2019 ($Million)
  • Table 17: North American Infectious Disease Diagnostics Market Size for Biochemical Characterization, By Country, 2012-2019 ($Million)
  • Table 18: Market Size for PCR, By Geography, 2012-2019 ($Million)
  • Table 19: North American Infectious Disease Diagnostics Market Size for PCR, By Country, 2012-2019 ($Million)
  • Table 20: Market Size for INAAT, By Geography, 2012-2019 ($Million)
  • Table 21: North American Infectious Disease Diagnostics Market Size for INAAT, By Country, 2012-2019 ($Million)
  • Table 22: Market Size for Hybridization, By Geography, 2012-2019 ($Million)
  • Table 23: North American Infectious Disease Diagnostics Market Size for Hybridization, By Country, 2012-2019 ($Million)
  • Table 24: Market Size for DNA Sequencing & NGS, By Geography, 2012-2019 ($Million)
  • Table 26: North American Infectious Disease Diagnostics Market Size for DNA Sequencing & NGS, By Country, 2012-2019 ($Million)
  • Table 27: Market Size for Microarray, By Geography, 2012-2019 ($Million)
  • Table 28: North American Infectious Disease Diagnostics Market Size for Microarray, By Country, 2012-2019 ($Million)
  • Table 29: Market Size for Others, By Geography, 2012-2019 ($Million)
  • Table 30: North American Infectious Disease Diagnostics Market Size for Others, By Country, 2012-2019 ($Million)
  • Table 31: Global Infectious Disease Diagnostics Market Size, By Application, 2012-2019 ($Million)
  • Table 32: Market Size for Hepatitis B, By Geography, 2012-2019 ($Million)
  • Table 33: North American Infectious Disease Diagnostics Market Size for Hepatitis B, By Country, 2012-2019 ($Million)
  • Table 34: Market Size for Hepatitis C, By Geography, 2012-2019 ($Million)
  • Table 35: North American Infectious Disease Diagnostics Market Size for Hepatitis C, By Country, 2012-2019 ($Million)
  • Table 36: Market Size for Aids, By Geography, 2012-2019 ($Million)
  • Table 37: North American Infectious Disease Diagnostics Market Size for Aids, By Country, 2012-2019 ($Million)
  • Table 38: Market Size for Tuberculosis, By Geography, 2012-2019 ($Million)
  • Table 39: North American Infectious Disease Diagnostics Market Size for Tuberculosis, By Country, 2012-2019 ($Million)
  • Table 40: Market Size for CT/NG, By Geography, 2012-2019 ($Million)
  • Table 41: Market Size for HPV, By Geography, 2012-2019 ($Million)
  • Table 42: Market Size for MRSA (Hospital Acquired Infection), By Geography, 2012-2019 ($Million)
  • Table 43: Market Size for Others, By Geography, 2012-2019 ($Million)
  • Table 44: Global Market Size, By End User, 2012-2019 ($Million)
  • Table 45: North America: Electron Market Size, By Type, 2012-2019 ($Million)
  • Table 46: Hospital Laboratories Infectious Disease Diagnostics Market Size, By Region , 2012-2019 ($Million)
  • Table 47: North America Hospital Laboratories Infectious Disease Diagnostics Market Size, By Country , 2012-2019 ($Million)
  • Table 48: Reference Labs Infectious Disease Diagnostics Market Size, By Region , 2012-2019 ($Million)
  • Table 49: North America Reference Labs Infectious Disease Diagnostics Market Size, By Country , 2012-2019 ($Million)
  • Table 50: Physician office Labs Infectious Disease Diagnostics Market Size, By Region , 2012-2019 ($Million))
  • Table 51: North America Physician office Labs Infectious Disease Diagnostics Market Size, By Country , 2012-2019 ($Million)
  • Table 52: Academics Infectious Disease Diagnostics Market Size, By Region , 2012-2019 ($Million))
  • Table 53: North America Academics Infectious Disease Diagnostics Market Size, By Country , 2012-2019 ($Million)
  • Table 54: Other End Users Infectious Disease Diagnostics Market Size, By Region , 2012-2019 ($Million)
  • Table 55: North America Other End Users Infectious Disease Diagnostics Market Size, By Country , 2012-2019 ($Million)
  • Table 56: Global Infectious Disease Diagnostics Market Size, By Region, 2012-2019 ($Million)
  • Table 57: North America: Market Size, By Country, 2012-2019 ($Million)
  • Table 58: North America: Market Size, By Technique, 2012-2019 ($Million)
  • Table 59: North America: Traditional Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 60: North America: Molecular Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 61: North America: Market Size, By Product, 2012-2019 ($Million)
  • Table 62: North America: Market Size, By Application, 2012-2019 ($Million)
  • Table 63: North America: Market Size, By End User, 2012-2019 ($Million)
  • Table 64: U.S. Market Size, By Technique, 2012-2019 ($Million)
  • Table 65: U.S. Traditional Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 66: U.S. Molecular Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 67: U.S. Market Size, By Product, 2012-2019 ($Million)
  • Table 68: U.S. Market Size, By Application, 2012-2019 ($Million)
  • Table 69: U.S. Market Size, By End User, 2012-2019 ($Million)
  • Table 70: Canada: Market Size, By Technique, 2012-2019 ($Million)
  • Table 71: Canada: Traditional Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 72: Canada: Molecular Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 73: Canada: Market Size, By Product, 2012-2019 ($Million)
  • Table 74: Canada: Market Size, By Application, 2012-2019 ($Million)
  • Table 75: Canada: Market Size, By End User, 2012-2019 ($Million)
  • Table 76: Europe: Market Size, By Technology, 2012-2019 ($Million)
  • Table 77: Europe: Traditional Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 78: Europe: Molecular Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 79: Europe: Market Size, By Application, 2012-2019 ($Million)
  • Table 80: Europe: Market Size, By End User, 2012-2019 ($Million)
  • Table 81: Asia-Pacific: Market Size, By Technique, 2012-2019 ($Million)
  • Table 82: Asia-Pacific: Traditional Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 83: Asia-Pacific: Molecular Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 84: Asia-Pacific: Market Size, By Product, 2012-2019 ($Million)
  • Table 85: Asia-Pacific: Market Size, By Application, 2012-2019 ($Million)
  • Table 86: Asia-Pacific: Market Size, By End User, 2012-2019 ($Million)
  • Table 87: ROW: Market Size, By Technique, 2012-2019 ($Million)
  • Table 88: ROW: Traditional Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 89: ROW: Molecular Infectious Disease Diagnostic Market Size, By Technique, 2012-2019 ($Million)
  • Table 90: ROW: Market Size, By Product, 2012-2019 ($Million)
  • Table 91: ROW: Market Size, By Application, 2012-2019 ($Million)
  • Table 92: ROW: Market Size, By End User, 2012-2019 ($Million)
  • Table 93: New Product Launches, 2011-2014
  • Table 94: Agreements, Partnerships, and Collaborations, 2011-2014
  • Table 95: Acquisitions, 2011-2014
  • Table 96: Expansions 2011-2014
  • Table 97: Other Developments, 2011-2014

List of Figures

  • Figure 1: Research Methodology
  • Figure 2: Market Size Estimation
  • Figure 3: Break Down of Primary Interviews: By Company Type, Designation, and Region
  • Figure 4: Market Snapshot (2014 Vs. 2019)
  • Figure 5: Global Market, By Application, 2014
  • Figure 6: Hospital Laboratories Are the Major End Users of the Market
  • Figure 7: Geographical Snapshot, 2014
  • Figure 8: New Product Launch is the Dominant Strategy Among the Market Players
  • Figure 9: Technological Advancements and Favorable Government Funding Are Important Growth Drivers
  • Figure 10: Consumables to Account for the Largest Share in Market
  • Figure 11: Asia-Pacific to Grow at the Highest Rate During the forecast Period
  • Figure 12: Hepatitis B Segment to Dominate the Infectious Disease Diagnostics Applications Market in 2014
  • Figure 13: Hospital Laboratories Are the Major End Users of the Market
  • Figure 14: Asia-Pacific Market Showcases Lucrative Growth Opportunities
  • Figure 15: Market Segmentation, By Product
  • Figure 16: Market Segmentation, By Application
  • Figure 17: Market Segmentation, By End User
  • Figure 18: Favorable Government & Corporate Funding to Boost Market Growth
  • Figure 19: Supply Chain Analysis
  • Figure 20: Development of POC Diagnostic Techniques is the Leading Trend Among Key Players
  • Figure 21: Market Players Adopted the Organic Growth Strategy of New Product Launches
  • Figure 22: Traditional Diagnostic Techniques Accounts for the Largest Share of the Overall Market in 2014
  • Figure 23: Infectious Disease Immunodiagnostics Segment Dominates the Traditional Diagnostic Techniques Market
  • Figure 24: Companies Adopted Product Innovation As Their Key Growth Strategy Over the Last Three Years
  • Figure 25: Global Market Share, By Key Player, 2013
  • Figure 26: Abbott Laboratories: Company Snapshot
  • Figure 27: Becton, Dickinson & Co.: Company Snapshot
  • Figure 28: Biomérieux: Company Snapshot
  • Figure 29: Bio-Rad Laboratories: Company Snapshot
  • Figure 30: Alere, Inc.: Company Snapshot
  • Figure 31: Thermo Fisher Scientific, Inc: Company Snapshot
  • Figure 32: Siemens Healthcare: Company Snapshot
  • Figure 33: Roche Diagnostics.: Company Snapshot
  • Figure 34: Danaher Corporation: Company Snapshot
  • Figure 35: Johnson and Johnson: Company Snapshot
Back to Top